[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627252":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":39,"responsibleParty":69,"collaborators":72,"id":75,"slug":76,"hasResults":77,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":18,"eligibilityCriteria":81,"healthyVolunteers":77,"sex":82,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":18,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":95,"overallStatus":104,"whyStopped":18,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"University of Lahore","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Group","EXPERIMENTAL","Participants will receive prescribed therapy review, routine medical checkups and access to nursing support. In addition, they will receive pharmacist-led monitoring of weight, waist circumference, blood pressure, fasting glucose, and lipid profile. They will also receive guidance on medication use and personalized lifestyle counseling.",[13],"Behavioral: Pharmacist monitoring and counseling to prevent or delay metabolic syndrome",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","Participants will only receive prescribed therapy review, routine medical checkups and access to nursing support. They will not receive structured pharmacist-led monitoring or lifestyle counseling.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Pharmacist monitoring and counseling to prevent or delay metabolic syndrome","Patients will have a 20-30 minutes meetings with a clinical pharmacist at baseline, week 4, 8, and 12. Pharmacist will do metabolic assessments at each visit and individually counsel the patient on diet, physical activity and weight management. He will educate the patient on medication use, metabolic syndrome, cardiovascular risk and weight gain due to second generation antipsychotics. Clinical Pharmacist will assess the following parameters:\n\n* Weight\n* Body mass index (BMI)\n* Waist circumference\n* Blood pressure\n* Fasting blood glucose\n* Lipid profile",[9],[26],{"name":27,"affiliation":28,"role":29},"Usman R Malik, PhD","Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan","PRINCIPAL_INVESTIGATOR",[31,35],{"name":27,"role":32,"phone":33,"phoneExt":18,"email":34},"CONTACT","+923096840007","usman.rashid@pharm.uol.edu.pk",{"name":36,"role":32,"phone":37,"phoneExt":18,"email":38},"Sundas Anees, Pharm.D","+923345517671","70178033@student.uol.edu.pk",[40,58],{"facility":41,"status":18,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Punjab Institute of Mental Health","Lahore","Punjab Province","54000","Pakistan","PK",{"type":48,"coordinates":49},"Point",[50,51],74.35071,31.558,{"lat":51,"lon":50},[54],{"name":55,"role":32,"phone":56,"phoneExt":18,"email":57},"Waqas Shabbir, Clinical Psychologist","+923315177898","shabbirwaqas1031@gmail.com",{"facility":59,"status":18,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":60,"geoPoint":62,"contacts":63},"The University of Lahore",{"type":48,"coordinates":61},[50,51],{"lat":51,"lon":50},[64,65,66,67],{"name":27,"role":32,"phone":33,"phoneExt":18,"email":34},{"name":36,"role":32,"phone":37,"phoneExt":18,"email":38},{"name":27,"role":29,"phone":18,"phoneExt":18,"email":18},{"name":36,"role":68,"phone":18,"phoneExt":18,"email":18},"SUB_INVESTIGATOR",{"type":29,"investigatorFullName":70,"investigatorTitle":71,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Usman Rashid Malik","Assistant Professor",[73],{"name":41,"class":74},"OTHER_GOV","100627252","pharmacist-led-interventions-in-psychiatric-patients-100627252",false,"NCT07446218","Pharmacist-led Interventions in Psychiatric Patients","Impact of Pharmacist-Led Interventions in Psychiatric Patients on Second Generation Antipsychotics","Inclusion Criteria:\n\n* Adults aged 18-60 years.\n* Diagnosed with schizophrenia, bipolar disorder, or major depressive disorder.\n* Currently prescribed a second-generation antipsychotic for \\\u003C 2 months.\n* Willing to participate in lifestyle and counseling sessions.\n\nExclusion Criteria:\n\n* Patients with severe medical comorbidities.\n* Pregnant or breastfeeding women.\n* Patients receiving only first-generation antipsychotics.\n* Patients taking more than three antipsychotics.\n* Patients using combination of first and second generation antipsychotics.\n* Individuals with cognitive impairment.\n* Patients with type 2 diabetes mellitus.","ALL","18 Years","60 Years",{"count":86,"type":87},148,"ESTIMATED","INTERVENTIONAL",[90],"NA","The goal of this intervention study is to examine the impact of pharmacist-led interventions in psychiatric patients initiating second-generation antipsychotic treatment. The primary purpose is to assess the impact of intervention on antipsychotic induced metabolic outcomes, such as weight gain and other cardiometabolic risk markers, in patients aged 18 to 60 years who have been diagnosed with chronic mental disorder. Participants will be assigned to either the intervention or the control group. The intervention group will receive educational interventions from the pharmacist at baseline, after 4 weeks, 8 weeks, and 12 weeks along with the standard therapy prescribed by the psychiatrist. On the other hand, the control group will receive only the standard therapy with no intervention from the pharmacist.",[93,94],"Mental Disorders","Metabolic Syndrome",[96,97,98,99,100,45,101,102,103],"severe mental illness","chronic mental disorder","atypical antipsychotics","intervention study","RCT","metabolic syndrome","second generation antipsychotics","educational intervention","NOT_YET_RECRUITING","2026-02-25",{"date":107,"type":108},"2026-03-03","ACTUAL",{"date":110,"type":87},"2026-03-01",{"date":112,"type":87},"2026-05-31",{"name":5,"class":6},2]